Adjuvant Therapy in Cervical Cancer Patients with High Risk Factors

Yonsei Medical Journal

Volumn 38, Issue 5, 1997, Pages 255-260

  Park, Tchan Kyu ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Adjuvant therapy; Cervical cancer; High risk factors

Indexed keywords

BIOLOGICAL PRODUCT;

ADJUVANT CHEMOTHERAPY; FEMALE; HUMAN; REVIEW; RISK FACTOR; UTERINE CERVIX TUMOR;

BIOLOGICAL PRODUCTS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0031241525     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1997.38.5.255     Document Type: Article

References (32)

1. Chang AYC, Keng PC: Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M Phase of the cell cycle. Cancer Res 47: 4338-4341, 1987
2. Cummings BJ: The place of radiation therapy in the treatment of carcinoma of the anal cancer. Cancer Treat Rev 9: 125-147, 1982
3. Deppe G, Valviya V, Han I, Christensen CW, Malone Jr JM, Kim Y, Ahmed K: A preliminary report of combination chemotherapy with cisplatin and mitomycin C followed by radical hysterectomy or radiation therapy in patients with locally advanced cervical cancer. Gynecol Oncol 42: 178-181, 1991
4. Drescher CW, Reid GC, Terada K, Roberts JA, Hopkins MP, Schoeppel SL: Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor prognosis squamous cell carcinoma of the uterine cervix. Gynecol Oncol 33: 225-230, 1989
5. Friedlander M, Atkinson K, Coppleson VM, Elliot P, Green D, Houghton R, Solomon H, Russell P: The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study. Gynecol Oncol 19: 1-7, 1984
6. Guthrie D: Chemotherapy of cervical cancer. Clin Obstet Gynecol 12: 229-246, 1985
7. International agency for research on cancer: Cancer Incidence in Five Continents, vol VI(Lyon : IARC Scientific Publications), 1992
8. Jampolis S, Andras EJ, Fletcher GH: Analysis of sites and causes of failure of irradiation in invasive squamous carcinoma of the cervix. Radiology 115: 681-685, 1975
9. Kersh CR, Constable WC, Hahn SS, Andersen WA, Talor PT: A phase I-II trial of multimodality management of bulky gynecologic malignancy. Cancer 38: 446-451, 1990
10. Kim DS, Moon H, Kim KT, Hwang YY, Cho SH, Kim SR: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage IB and II with Bulky tumor. Gynecol Oncol 33: 225-230, 1989
11. Korean cancer research foundation: Implantation Study of Seoul Cancer Registry(Seoul: KCRF Publication), 1993
12. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Hong WK, Massimini G, Krakoff IH: 13-cis-retinoic acid plus interferon-α2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst 85: 499-500, 1993
13. Malviya VK, Deppe G, Kim Y, Gove N: Concurrent radiation therapy, cisplatin and mitomycin C in patients with poor prognosis cancer of the cervix: a pilot study. Am J Clin Oncol 12: 434-437, 1989
14. Panici BP, Scambia G, Greggi S, Gallo A: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer: Prognostic factors for response and survival. Cancer 67: 372-379, 1991
15. Park TK: Carcinoma of the uterine cervix in Korea: an analysis of treatment failures and suggested therapeutic strategies. Korean J Obstet Gynecol 29: 617, 1986
16. Park TK, Choi DH, Kim SN, Lee CH, Kim YT, Kim GE, Suh CO, Loh JK: Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 41: 107-112, 1991
17. Park TK, Lee JP, Kim SN, Choi SM, Kudelka AP, Kavanagh JJ: Interferon-α2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study. Eur J Gynecol Oncol, accepted
18. Park TK, Lee SK, Kim SN, Hwang TS, Kim GE, Suh CO, Loh JK: Combined chemotherapy and radiation for bulky stages I-II cervical cancer; Comparison of concurrent and sequential regimens. Gynecol Oncol 50: 196-201, 1993
19. Perez CA, Breaux S, Madoc-Jones H, Bedwine KJM, Camel HM, Walz BJ: Radiation therapy alone in the treatment of carcinoma of the cervix. 1. Analysis of tumor recurrence. Cancer 51: 1393-1402, 1983
20. Piver MS, Chung WS: Prognostic significance of cervical lesion size and pelvic node metastasis in cervical carcinoma. Obstet Gynecol 46: 507-510, 1975
21. Roberts WS, Hoffman MS, Kavanagh JJ, Fiorica JV, Greenberg H, Finan MA, Cavanagh D: Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol Oncol 43: 233-236, 1991
22. Sardi J, Sananes C, Giaroli A, Maya G, DiPaola G: Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38: 486-493, 1990
23. Souhatni L, Canary PC, Araujo CM, Pinto LH, Silveira TR: A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 9: 970-977, 1991
24. Symonds RP, Burnett RA, Habeshow T, Kaye SB, Snee MP, Watson ER: The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix. Br J Cancer 59: 473-475, 1989
25. Thigpen T, Shingleton H, Homesley H, Lagasse L, Bressing J: Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix. A phase II study of the Gynecologic oncology group. Cancer 481: 899-903, 1981
26. Thomas GM, Dembo AJ, Black B, Bean HA, Beale FA, Pringle JR, Radwing G: Concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after radical surgery. Gynecol Oncol 27: 254-260, 1987
27. Thomas G, Dembo A, Fyles A, Gadalla T, Beale F, Bean H, Bush R, Balck B: Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 38: 446-451, 1990
28. Tseng CJ, Chang CT, Lai CH, Soong YK, Hong JH, Tung SG, Hsueh S : A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66: 52-58, 1997
29. Van Nagell JR Jr, Donaldson ES, Parker JC, Van Dyke AH, Wood EG: Prognostic significance of pelvic node morphology in carcinoma of the uterine cervix. Cancer 39: 2624-2632, 1977
30. Vermund H, Gollin FF: Mechanism of action of radiotherapy and chemotherapeutic adjuvants-A review. Cancer 21: 58-76, 1968
31. Withers HR, Talor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27: 131-146, 1988
32. Zanetta G, Landoni F, Colombo A, Maneo A, Leventis C: Three-year results after neoadjuvant chemotherapy, radical surgery and radiotherapy in locally advanced cervical carcinoma. Obstet Gynecol 82: 447-450, 1993